Loading…

Standardized Mitotic Counts in Breast Cancer Evaluation of the Method

Twenty-one pathologists and technicians participated in a study evaluating the variation present in mitotic counts for prognostication of breast cancer. The participants counted the mitotic figures in 20 breast cancer samples from ten high power fields (mitotic activity index, MAI, giving the result...

Full description

Saved in:
Bibliographic Details
Published in:Pathology, research and practice research and practice, 1996-09, Vol.192 (9), p.931-941
Main Authors: Collan, Y.U.I., Kuopio, T., Baak, J.P.A., Becker, R., Bogomoletz, W.V., Deverell, M., Van Diest, P., Van Galen, C., Gilchrist, K., Javed, A., Kosma, V.-M., Kujari, H., Luzi, P., Mariuzzi, G.M., Matze, E., Montironi, R., Scarpelli, M., Sierra, D., Sisti, S., Toikkanen, S., Tosi, P., Whimster, W.F., Wisse, E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-26605d6b79298711bd3d0b1e5ffaf4ae7cb89f917af6f50667272b43bcb7bed73
cites cdi_FETCH-LOGICAL-c362t-26605d6b79298711bd3d0b1e5ffaf4ae7cb89f917af6f50667272b43bcb7bed73
container_end_page 941
container_issue 9
container_start_page 931
container_title Pathology, research and practice
container_volume 192
creator Collan, Y.U.I.
Kuopio, T.
Baak, J.P.A.
Becker, R.
Bogomoletz, W.V.
Deverell, M.
Van Diest, P.
Van Galen, C.
Gilchrist, K.
Javed, A.
Kosma, V.-M.
Kujari, H.
Luzi, P.
Mariuzzi, G.M.
Matze, E.
Montironi, R.
Scarpelli, M.
Sierra, D.
Sisti, S.
Toikkanen, S.
Tosi, P.
Whimster, W.F.
Wisse, E.
description Twenty-one pathologists and technicians participated in a study evaluating the variation present in mitotic counts for prognostication of breast cancer. The participants counted the mitotic figures in 20 breast cancer samples from ten high power fields (mitotic activity index, MAI, giving the results in mitotic figures per 10 fields) and also made a correction for field size and area fraction o f the neoplastic epithelium to get the standardized mitotic index (volume fraction corrected mitotic index, or M/Vv index, giving the result in mitotic figures per square mm o f neoplastic epithelium). The difference in variation between the two methods was not big, but the standardized mitotic index (SMI) showed consistently smaller variation among all participants and different subgroups. Experienced pathologists had the highest variation in mitotic counts, and specially trained technicians, the lowest. The efficiency o f the mitotic counts in grading (the grading efficiency) was used to evaluate the mitotic counts. I n groups without special training for mitotic counts the mean grading efficiency was lower (experienced and training pathologists both on average had the potential to grade 88% o f the cases correctly) than in the group specially trained for the purpose (trained technicians had the potential to grade 9S% o f the cases correctly). Among the specially trained technicians, the grading efficiency was o f the same magnitude as the grading efficiency achieved in determining the S-Phase fraction of cells from paraffin embedded breast cancers by flow cytometry in different laboratories. The results suggest that special training is helpful in making mitotic counts more reproducible, and that in trained hands, the mitotic counts give results comparable to more sophisticated methods o f determining proli ferative activity in breast cancer.
doi_str_mv 10.1016/S0344-0338(96)80075-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78584685</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0344033896800756</els_id><sourcerecordid>78584685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-26605d6b79298711bd3d0b1e5ffaf4ae7cb89f917af6f50667272b43bcb7bed73</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotV4eQchKdDGazCXJrERLvYDFRXUdcjnBSDupSUbQp3dqS7euzuL__nM4H0JnlFxRQtn1nFR1XZCqEhctuxSE8KZge2hMGRUFYRXdR-MdcoiOUvogA0RqOkIj0TaEMzJG03lWnVXR-h-weOZzyN7gSei7nLDv8F0ElTKeqM5AxNMvtehV9qHDweH8DngG-T3YE3Tg1CLB6XYeo7f76evksXh-eXia3D4XpmJlLkrGSGOZ5m3ZCk6ptpUlmkLjnHK1Am60aF1LuXLMNYQxXvJS15U2mmuwvDpG55u9qxg-e0hZLn0ysFioDkKfJBeNqJloBrDZgCaGlCI4uYp-qeK3pESu9ck_fXLtRrZM_umTbOidbQ_0egl219r6GvKbTQ7Dl18eokzGw-DG-ggmSxv8Pxd-Ac7NfuU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78584685</pqid></control><display><type>article</type><title>Standardized Mitotic Counts in Breast Cancer Evaluation of the Method</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Collan, Y.U.I. ; Kuopio, T. ; Baak, J.P.A. ; Becker, R. ; Bogomoletz, W.V. ; Deverell, M. ; Van Diest, P. ; Van Galen, C. ; Gilchrist, K. ; Javed, A. ; Kosma, V.-M. ; Kujari, H. ; Luzi, P. ; Mariuzzi, G.M. ; Matze, E. ; Montironi, R. ; Scarpelli, M. ; Sierra, D. ; Sisti, S. ; Toikkanen, S. ; Tosi, P. ; Whimster, W.F. ; Wisse, E.</creator><creatorcontrib>Collan, Y.U.I. ; Kuopio, T. ; Baak, J.P.A. ; Becker, R. ; Bogomoletz, W.V. ; Deverell, M. ; Van Diest, P. ; Van Galen, C. ; Gilchrist, K. ; Javed, A. ; Kosma, V.-M. ; Kujari, H. ; Luzi, P. ; Mariuzzi, G.M. ; Matze, E. ; Montironi, R. ; Scarpelli, M. ; Sierra, D. ; Sisti, S. ; Toikkanen, S. ; Tosi, P. ; Whimster, W.F. ; Wisse, E.</creatorcontrib><description>Twenty-one pathologists and technicians participated in a study evaluating the variation present in mitotic counts for prognostication of breast cancer. The participants counted the mitotic figures in 20 breast cancer samples from ten high power fields (mitotic activity index, MAI, giving the results in mitotic figures per 10 fields) and also made a correction for field size and area fraction o f the neoplastic epithelium to get the standardized mitotic index (volume fraction corrected mitotic index, or M/Vv index, giving the result in mitotic figures per square mm o f neoplastic epithelium). The difference in variation between the two methods was not big, but the standardized mitotic index (SMI) showed consistently smaller variation among all participants and different subgroups. Experienced pathologists had the highest variation in mitotic counts, and specially trained technicians, the lowest. The efficiency o f the mitotic counts in grading (the grading efficiency) was used to evaluate the mitotic counts. I n groups without special training for mitotic counts the mean grading efficiency was lower (experienced and training pathologists both on average had the potential to grade 88% o f the cases correctly) than in the group specially trained for the purpose (trained technicians had the potential to grade 9S% o f the cases correctly). Among the specially trained technicians, the grading efficiency was o f the same magnitude as the grading efficiency achieved in determining the S-Phase fraction of cells from paraffin embedded breast cancers by flow cytometry in different laboratories. The results suggest that special training is helpful in making mitotic counts more reproducible, and that in trained hands, the mitotic counts give results comparable to more sophisticated methods o f determining proli ferative activity in breast cancer.</description><identifier>ISSN: 0344-0338</identifier><identifier>EISSN: 1618-0631</identifier><identifier>DOI: 10.1016/S0344-0338(96)80075-6</identifier><identifier>PMID: 8950760</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Breast cancer ; Breast Neoplasms - pathology ; Grading efficiency ; Humans ; M/Vv index ; MAI ; Mitotic Index - genetics ; Observer Variation ; Pathology, Surgical - standards ; Proliferative activity ; Reference Standards ; SMI ; Standardized mitotic index</subject><ispartof>Pathology, research and practice, 1996-09, Vol.192 (9), p.931-941</ispartof><rights>1996 Gustav Fischer Verlag, Stuttgart</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-26605d6b79298711bd3d0b1e5ffaf4ae7cb89f917af6f50667272b43bcb7bed73</citedby><cites>FETCH-LOGICAL-c362t-26605d6b79298711bd3d0b1e5ffaf4ae7cb89f917af6f50667272b43bcb7bed73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8950760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Collan, Y.U.I.</creatorcontrib><creatorcontrib>Kuopio, T.</creatorcontrib><creatorcontrib>Baak, J.P.A.</creatorcontrib><creatorcontrib>Becker, R.</creatorcontrib><creatorcontrib>Bogomoletz, W.V.</creatorcontrib><creatorcontrib>Deverell, M.</creatorcontrib><creatorcontrib>Van Diest, P.</creatorcontrib><creatorcontrib>Van Galen, C.</creatorcontrib><creatorcontrib>Gilchrist, K.</creatorcontrib><creatorcontrib>Javed, A.</creatorcontrib><creatorcontrib>Kosma, V.-M.</creatorcontrib><creatorcontrib>Kujari, H.</creatorcontrib><creatorcontrib>Luzi, P.</creatorcontrib><creatorcontrib>Mariuzzi, G.M.</creatorcontrib><creatorcontrib>Matze, E.</creatorcontrib><creatorcontrib>Montironi, R.</creatorcontrib><creatorcontrib>Scarpelli, M.</creatorcontrib><creatorcontrib>Sierra, D.</creatorcontrib><creatorcontrib>Sisti, S.</creatorcontrib><creatorcontrib>Toikkanen, S.</creatorcontrib><creatorcontrib>Tosi, P.</creatorcontrib><creatorcontrib>Whimster, W.F.</creatorcontrib><creatorcontrib>Wisse, E.</creatorcontrib><title>Standardized Mitotic Counts in Breast Cancer Evaluation of the Method</title><title>Pathology, research and practice</title><addtitle>Pathol Res Pract</addtitle><description>Twenty-one pathologists and technicians participated in a study evaluating the variation present in mitotic counts for prognostication of breast cancer. The participants counted the mitotic figures in 20 breast cancer samples from ten high power fields (mitotic activity index, MAI, giving the results in mitotic figures per 10 fields) and also made a correction for field size and area fraction o f the neoplastic epithelium to get the standardized mitotic index (volume fraction corrected mitotic index, or M/Vv index, giving the result in mitotic figures per square mm o f neoplastic epithelium). The difference in variation between the two methods was not big, but the standardized mitotic index (SMI) showed consistently smaller variation among all participants and different subgroups. Experienced pathologists had the highest variation in mitotic counts, and specially trained technicians, the lowest. The efficiency o f the mitotic counts in grading (the grading efficiency) was used to evaluate the mitotic counts. I n groups without special training for mitotic counts the mean grading efficiency was lower (experienced and training pathologists both on average had the potential to grade 88% o f the cases correctly) than in the group specially trained for the purpose (trained technicians had the potential to grade 9S% o f the cases correctly). Among the specially trained technicians, the grading efficiency was o f the same magnitude as the grading efficiency achieved in determining the S-Phase fraction of cells from paraffin embedded breast cancers by flow cytometry in different laboratories. The results suggest that special training is helpful in making mitotic counts more reproducible, and that in trained hands, the mitotic counts give results comparable to more sophisticated methods o f determining proli ferative activity in breast cancer.</description><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Grading efficiency</subject><subject>Humans</subject><subject>M/Vv index</subject><subject>MAI</subject><subject>Mitotic Index - genetics</subject><subject>Observer Variation</subject><subject>Pathology, Surgical - standards</subject><subject>Proliferative activity</subject><subject>Reference Standards</subject><subject>SMI</subject><subject>Standardized mitotic index</subject><issn>0344-0338</issn><issn>1618-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkMtKAzEUhoMotV4eQchKdDGazCXJrERLvYDFRXUdcjnBSDupSUbQp3dqS7euzuL__nM4H0JnlFxRQtn1nFR1XZCqEhctuxSE8KZge2hMGRUFYRXdR-MdcoiOUvogA0RqOkIj0TaEMzJG03lWnVXR-h-weOZzyN7gSei7nLDv8F0ElTKeqM5AxNMvtehV9qHDweH8DngG-T3YE3Tg1CLB6XYeo7f76evksXh-eXia3D4XpmJlLkrGSGOZ5m3ZCk6ptpUlmkLjnHK1Am60aF1LuXLMNYQxXvJS15U2mmuwvDpG55u9qxg-e0hZLn0ysFioDkKfJBeNqJloBrDZgCaGlCI4uYp-qeK3pESu9ck_fXLtRrZM_umTbOidbQ_0egl219r6GvKbTQ7Dl18eokzGw-DG-ggmSxv8Pxd-Ac7NfuU</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>Collan, Y.U.I.</creator><creator>Kuopio, T.</creator><creator>Baak, J.P.A.</creator><creator>Becker, R.</creator><creator>Bogomoletz, W.V.</creator><creator>Deverell, M.</creator><creator>Van Diest, P.</creator><creator>Van Galen, C.</creator><creator>Gilchrist, K.</creator><creator>Javed, A.</creator><creator>Kosma, V.-M.</creator><creator>Kujari, H.</creator><creator>Luzi, P.</creator><creator>Mariuzzi, G.M.</creator><creator>Matze, E.</creator><creator>Montironi, R.</creator><creator>Scarpelli, M.</creator><creator>Sierra, D.</creator><creator>Sisti, S.</creator><creator>Toikkanen, S.</creator><creator>Tosi, P.</creator><creator>Whimster, W.F.</creator><creator>Wisse, E.</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960901</creationdate><title>Standardized Mitotic Counts in Breast Cancer Evaluation of the Method</title><author>Collan, Y.U.I. ; Kuopio, T. ; Baak, J.P.A. ; Becker, R. ; Bogomoletz, W.V. ; Deverell, M. ; Van Diest, P. ; Van Galen, C. ; Gilchrist, K. ; Javed, A. ; Kosma, V.-M. ; Kujari, H. ; Luzi, P. ; Mariuzzi, G.M. ; Matze, E. ; Montironi, R. ; Scarpelli, M. ; Sierra, D. ; Sisti, S. ; Toikkanen, S. ; Tosi, P. ; Whimster, W.F. ; Wisse, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-26605d6b79298711bd3d0b1e5ffaf4ae7cb89f917af6f50667272b43bcb7bed73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Grading efficiency</topic><topic>Humans</topic><topic>M/Vv index</topic><topic>MAI</topic><topic>Mitotic Index - genetics</topic><topic>Observer Variation</topic><topic>Pathology, Surgical - standards</topic><topic>Proliferative activity</topic><topic>Reference Standards</topic><topic>SMI</topic><topic>Standardized mitotic index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Collan, Y.U.I.</creatorcontrib><creatorcontrib>Kuopio, T.</creatorcontrib><creatorcontrib>Baak, J.P.A.</creatorcontrib><creatorcontrib>Becker, R.</creatorcontrib><creatorcontrib>Bogomoletz, W.V.</creatorcontrib><creatorcontrib>Deverell, M.</creatorcontrib><creatorcontrib>Van Diest, P.</creatorcontrib><creatorcontrib>Van Galen, C.</creatorcontrib><creatorcontrib>Gilchrist, K.</creatorcontrib><creatorcontrib>Javed, A.</creatorcontrib><creatorcontrib>Kosma, V.-M.</creatorcontrib><creatorcontrib>Kujari, H.</creatorcontrib><creatorcontrib>Luzi, P.</creatorcontrib><creatorcontrib>Mariuzzi, G.M.</creatorcontrib><creatorcontrib>Matze, E.</creatorcontrib><creatorcontrib>Montironi, R.</creatorcontrib><creatorcontrib>Scarpelli, M.</creatorcontrib><creatorcontrib>Sierra, D.</creatorcontrib><creatorcontrib>Sisti, S.</creatorcontrib><creatorcontrib>Toikkanen, S.</creatorcontrib><creatorcontrib>Tosi, P.</creatorcontrib><creatorcontrib>Whimster, W.F.</creatorcontrib><creatorcontrib>Wisse, E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology, research and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Collan, Y.U.I.</au><au>Kuopio, T.</au><au>Baak, J.P.A.</au><au>Becker, R.</au><au>Bogomoletz, W.V.</au><au>Deverell, M.</au><au>Van Diest, P.</au><au>Van Galen, C.</au><au>Gilchrist, K.</au><au>Javed, A.</au><au>Kosma, V.-M.</au><au>Kujari, H.</au><au>Luzi, P.</au><au>Mariuzzi, G.M.</au><au>Matze, E.</au><au>Montironi, R.</au><au>Scarpelli, M.</au><au>Sierra, D.</au><au>Sisti, S.</au><au>Toikkanen, S.</au><au>Tosi, P.</au><au>Whimster, W.F.</au><au>Wisse, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Standardized Mitotic Counts in Breast Cancer Evaluation of the Method</atitle><jtitle>Pathology, research and practice</jtitle><addtitle>Pathol Res Pract</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>192</volume><issue>9</issue><spage>931</spage><epage>941</epage><pages>931-941</pages><issn>0344-0338</issn><eissn>1618-0631</eissn><abstract>Twenty-one pathologists and technicians participated in a study evaluating the variation present in mitotic counts for prognostication of breast cancer. The participants counted the mitotic figures in 20 breast cancer samples from ten high power fields (mitotic activity index, MAI, giving the results in mitotic figures per 10 fields) and also made a correction for field size and area fraction o f the neoplastic epithelium to get the standardized mitotic index (volume fraction corrected mitotic index, or M/Vv index, giving the result in mitotic figures per square mm o f neoplastic epithelium). The difference in variation between the two methods was not big, but the standardized mitotic index (SMI) showed consistently smaller variation among all participants and different subgroups. Experienced pathologists had the highest variation in mitotic counts, and specially trained technicians, the lowest. The efficiency o f the mitotic counts in grading (the grading efficiency) was used to evaluate the mitotic counts. I n groups without special training for mitotic counts the mean grading efficiency was lower (experienced and training pathologists both on average had the potential to grade 88% o f the cases correctly) than in the group specially trained for the purpose (trained technicians had the potential to grade 9S% o f the cases correctly). Among the specially trained technicians, the grading efficiency was o f the same magnitude as the grading efficiency achieved in determining the S-Phase fraction of cells from paraffin embedded breast cancers by flow cytometry in different laboratories. The results suggest that special training is helpful in making mitotic counts more reproducible, and that in trained hands, the mitotic counts give results comparable to more sophisticated methods o f determining proli ferative activity in breast cancer.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>8950760</pmid><doi>10.1016/S0344-0338(96)80075-6</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0344-0338
ispartof Pathology, research and practice, 1996-09, Vol.192 (9), p.931-941
issn 0344-0338
1618-0631
language eng
recordid cdi_proquest_miscellaneous_78584685
source ScienceDirect Freedom Collection 2022-2024
subjects Breast cancer
Breast Neoplasms - pathology
Grading efficiency
Humans
M/Vv index
MAI
Mitotic Index - genetics
Observer Variation
Pathology, Surgical - standards
Proliferative activity
Reference Standards
SMI
Standardized mitotic index
title Standardized Mitotic Counts in Breast Cancer Evaluation of the Method
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A56%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Standardized%20Mitotic%20Counts%20in%20Breast%20Cancer%20Evaluation%20of%20the%20Method&rft.jtitle=Pathology,%20research%20and%20practice&rft.au=Collan,%20Y.U.I.&rft.date=1996-09-01&rft.volume=192&rft.issue=9&rft.spage=931&rft.epage=941&rft.pages=931-941&rft.issn=0344-0338&rft.eissn=1618-0631&rft_id=info:doi/10.1016/S0344-0338(96)80075-6&rft_dat=%3Cproquest_cross%3E78584685%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-26605d6b79298711bd3d0b1e5ffaf4ae7cb89f917af6f50667272b43bcb7bed73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78584685&rft_id=info:pmid/8950760&rfr_iscdi=true